• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.16% Nasdaq Down 0.08%

    Delcath Systems, Inc. (DCTH)

    -NasdaqCM
    0.91 Down 0.01(1.02%) Jul 2, 3:59PM EDT
    Add to Portfolio
    Prev Close:0.92
    Open:0.90
    Bid:0.80 x 10000
    Ask:0.92 x 1900
    1y Target Est:1.30
    Beta:0.64
    Earnings Date:Aug 4 - Aug 10 (Est.)
    Day's Range:0.90 - 0.95
    52wk Range:0.80 - 2.78
    Volume:35,784
    Avg Vol (3m):488,254
    Market Cap:11.08M
    P/E (ttm):N/A
    EPS (ttm):-1.59
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for DCTH

    Comparison

    Symbol% ChgMkt Cap
    DCTHDown 1.02%11.08M
    LLYUp 1.52%91.22B
    PFEDown 0.95%205.48B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):9.31
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :N/A
    Quarterly EPS Est (Jun-14) :N/A
    Mean Recommendation*:4.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Delcath Systems, Inc. operates as a specialty pharmaceutical and medical device company focusing on cancers of the liver. The company is developing its proprietary product-Melphalan Hydrochloride for injection for use with the Delcath Hepatic Deli... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback